CGRPTargeted Therapies for Migraine Brand Name and Drug
Treatment, Prevention, or Both
How Administered
Therapy Type
Dosage
AIMOVIG (Erenumab-Aooe)
Prevention
Subcutaneous injection
Monoclonal antibodies (mAb)
One or two shots (70 mg) per month
AJOVY (Fremanezumab)
Prevention
Subcutaneous injection
mAb
One shot (225 mg) per month or three shots (675 mg) every three months
EMGALITY (Galcanezumabgnim)
Prevention
Subcutaneous injection
mAb
Two shots (120 mg each) the first month; one shot per month thereafter
VYEPTI (eptinezumabjjmr)
Prevention
Intravenous infusion
mAb
100 mg IV every three months
NURTEC ODT (rimegepant)
Acute treatment; prevention
Pill form
gepant
One 75 mg pill once every other day
UBRELVY (Ubrogepant)
Acute treatment
Pill form
gepant
50 or 100 milligrams (mg) per day, as needed
Dana.org
27